(Reuters) - It also recommended Novartis AG's Rasilez,
Enviage, Sprimeo, Tekturna and Riprazo for hypertension and
three biosimilar medicines -- Binocrit from Sandoz GmbH, Epoetin
alfa Hexal from Hexal Biotech Forschungs GmbH, and Abseamed from
Medice Arzneimittel Pütter GMBH & Co.
Recommendations for marketing approval by the Committee for
Medicinal Products for Human Use are normally endorsed by the
European Commission within 90 days.
Read more at Reuters.com Government Filings News
Enviage, Sprimeo, Tekturna and Riprazo for hypertension and
three biosimilar medicines -- Binocrit from Sandoz GmbH, Epoetin
alfa Hexal from Hexal Biotech Forschungs GmbH, and Abseamed from
Medice Arzneimittel Pütter GMBH & Co.
Recommendations for marketing approval by the Committee for
Medicinal Products for Human Use are normally endorsed by the
European Commission within 90 days.
Read more at Reuters.com Government Filings News
No comments:
Post a Comment